NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
TFF Pharmaceuticals Inc (NASDAQ: TFFP)
TFFP Technical Analysis
5
As on 12th Dec 2024 TFFP STOCK Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.68 & Strong Sell for SHORT-TERM with Stoploss of 0.39 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TFFPSTOCK Price
Open | 0.09 | Change | Price | % |
High | 0.09 | 1 Day | -0.10 | -62.50 |
Low | 0.06 | 1 Week | -0.25 | -80.65 |
Close | 0.06 | 1 Month | -2.45 | -97.61 |
Volume | 10125091 | 1 Year | -0.37 | -86.05 |
52 Week High 8.99 | 52 Week Low 0.22 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
APTO | 0.28 | 64.71% |
NVDA | 134.70 | 3.08% |
TNXP | 0.61 | 7.02% |
LCID | 3.02 | 14.83% |
TAOP | 0.41 | 28.12% |
AVGO | 220.79 | 1.13% |
TSLA | 421.06 | -3.46% |
QUBT | 17.62 | 16.38% |
AAPL | 254.49 | 1.88% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
TFFP Daily Charts |
TFFP Intraday Charts |
Whats New @ Bazaartrend |
TFFP Free Analysis |
|
TFFP Important Levels Intraday
RESISTANCE | 0.12 |
RESISTANCE | 0.10 |
RESISTANCE | 0.09 |
RESISTANCE | 0.08 |
SUPPORT | 0.04 |
SUPPORT | 0.03 |
SUPPORT | 0.02 |
SUPPORT | 0.00 |
TFFP Forecast December 2024
4th UP Forecast | 0.43 |
3rd UP Forecast | 0.31 |
2nd UP Forecast | 0.24 |
1st UP Forecast | 0.16 |
1st DOWN Forecast | -0.04 |
2nd DOWN Forecast | -0.12 |
3rd DOWN Forecast | -0.19 |
4th DOWN Forecast | -0.31 |
TFFP Weekly Forecast
4th UP Forecast | 0.29 |
3rd UP Forecast | 0.22 |
2nd UP Forecast | 0.17 |
1st UP Forecast | 0.13 |
1st DOWN Forecast | -0.01 |
2nd DOWN Forecast | -0.05 |
3rd DOWN Forecast | -0.10 |
4th DOWN Forecast | -0.17 |
TFFP Forecast2024
4th UP Forecast | 21.14 |
3rd UP Forecast | 14.38 |
2nd UP Forecast | 10.2 |
1st UP Forecast | 6.02 |
1st DOWN Forecast | -5.9 |
2nd DOWN Forecast | -10.08 |
3rd DOWN Forecast | -14.26 |
4th DOWN Forecast | -21.02 |
TFF Pharmaceuticals Inc ( NASDAQ USA Symbol : TFFP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TFFP Other Details
Segment | EQ | |
Market Capital | 195870288.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
TFFP Address
TFFP Latest News
TFFP Business Profile
TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform in the United States and Australia. It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which has completed Phase I clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in the Phase I clinical trials used for the prevention of lung transplant rejection. It is also developing other dry powder products, such as Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various types of pain; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas. Address: 2600 Via Fortuna, Austin, TX, United States, 78746
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service